Novogene Co., Ltd. (SHA:688315)
China flag China · Delayed Price · Currency is CNY
17.36
-0.65 (-3.61%)
Nov 17, 2026, 3:00 PM CST

Novogene Statistics

Total Valuation

Novogene has a market cap or net worth of CNY 7.03 billion. The enterprise value is 5.37 billion.

Market Cap7.03B
Enterprise Value 5.37B

Important Dates

The last earnings date was Thursday, October 29, 2026.

Earnings Date Oct 29, 2026
Ex-Dividend Date Jun 10, 2026

Share Statistics

Novogene has 405.06 million shares outstanding. The number of shares has decreased by -0.40% in one year.

Current Share Class 405.06M
Shares Outstanding 405.06M
Shares Change (YoY) -0.40%
Shares Change (QoQ) +11.91%
Owned by Insiders (%) 53.03%
Owned by Institutions (%) 4.82%
Float 136.73M

Valuation Ratios

The trailing PE ratio is 46.84 and the forward PE ratio is 37.47.

PE Ratio 46.84
Forward PE 37.47
PS Ratio 3.06
PB Ratio 2.59
P/TBV Ratio 2.62
P/FCF Ratio 34.27
P/OCF Ratio 20.13
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.86, with an EV/FCF ratio of 26.15.

EV / Earnings 35.74
EV / Sales 2.33
EV / EBITDA 18.86
EV / EBIT 34.96
EV / FCF 26.15

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.02.

Current Ratio 2.60
Quick Ratio 2.18
Debt / Equity 0.02
Debt / EBITDA 0.23
Debt / FCF 0.32
Interest Coverage 57.68

Financial Efficiency

Return on equity (ROE) is 5.78% and return on invested capital (ROIC) is 13.07%.

Return on Equity (ROE) 5.78%
Return on Assets (ROA) 2.51%
Return on Invested Capital (ROIC) 13.07%
Return on Capital Employed (ROCE) 5.47%
Weighted Average Cost of Capital (WACC) 8.41%
Revenue Per Employee 1.03M
Profits Per Employee 67,491
Employee Count2,227
Asset Turnover 0.60
Inventory Turnover 4.55

Taxes

In the past 12 months, Novogene has paid 18.72 million in taxes.

Income Tax 18.72M
Effective Tax Rate 10.79%

Stock Price Statistics

The stock price has increased by +16.82% in the last 52 weeks. The beta is 0.76, so Novogene's price volatility has been lower than the market average.

Beta (5Y) 0.76
52-Week Price Change +16.82%
50-Day Moving Average 17.56
200-Day Moving Average 15.10
Relative Strength Index (RSI) 45.88
Average Volume (20 Days) 22,455,596

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novogene had revenue of CNY 2.30 billion and earned 150.17 million in profits. Earnings per share was 0.37.

Revenue2.30B
Gross Profit 989.82M
Operating Income 153.51M
Pretax Income 173.55M
Net Income 150.17M
EBITDA 263.97M
EBIT 153.51M
Earnings Per Share (EPS) 0.37
Full Income Statement

Balance Sheet

The company has 1.76 billion in cash and 65.02 million in debt, with a net cash position of 1.69 billion or 4.18 per share.

Cash & Cash Equivalents 1.76B
Total Debt 65.02M
Net Cash 1.69B
Net Cash Per Share 4.18
Equity (Book Value) 2.74B
Book Value Per Share 6.69
Working Capital 1.79B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 349.25 million and capital expenditures -144.04 million, giving a free cash flow of 205.21 million.

Operating Cash Flow 349.25M
Capital Expenditures -144.04M
Depreciation & Amortization 110.45M
Net Borrowing -17.02M
Free Cash Flow 205.21M
FCF Per Share 0.51
Full Cash Flow Statement

Margins

Gross margin is 43.05%, with operating and profit margins of 6.68% and 6.53%.

Gross Margin 43.05%
Operating Margin 6.68%
Pretax Margin 7.55%
Profit Margin 6.53%
EBITDA Margin 11.48%
EBIT Margin 6.68%
FCF Margin 8.92%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.26%.

Dividend Per Share 0.05
Dividend Yield 0.26%
Dividend Growth (YoY) -10.00%
Years of Dividend Growth 2
Payout Ratio 12.14%
FCF Payout Ratio 8.88%
Buyback Yield 0.40%
Shareholder Yield 0.65%
Earnings Yield 2.14%
FCF Yield 2.92%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for Novogene is 19.53, which is 12.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target 19.53
Price Target Difference 12.50%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (3Y) 9.72%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Novogene has an Altman Z-Score of 4.66 and a Piotroski F-Score of 5.

Altman Z-Score 4.66
Piotroski F-Score 5